Exelixis (EXEL) Accumulated Expenses (2010 - 2026)
Exelixis' (EXEL) quarterly Accumulated Expenses came in at $87.5 million in Q2 2026, down 2.49% year-on-year from $89.7 million in Q2 2025, and down 14.39% quarter-over-quarter from $102.2 million in Q1 2026.
Exelixis (EXEL) Accumulated Expenses (2010 - 2026) Analysis & Trends
Exelixis' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $87.5 million for Q2 2026.
- On a quarterly basis, Accumulated Expenses fell 2.49% year-over-year to $87.5 million in Q2 2026; TTM through Apr 2026 was $87.5 million, a 2.49% decrease from a year earlier, with the FY2026 full-year figure at $102.2 million, down 6.93% from the prior year.
- Accumulated Expenses fell to $87.5 million in Q2 2026 per EXEL's latest filing, from $102.2 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $109.8 million in Q1 2025 and bottomed at $42.8 million in Q2 2022.
- The 5-year median for Accumulated Expenses is $77.2 million (2022), against an average of $79.4 million.
- Across the five-year window, Accumulated Expenses surged 32.23% in 2023 and retreated 6.93% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $77.2 million in 2022, then rose by 20.95% to $93.3 million in 2023, then fell by 2.91% to $90.6 million in 2024, then increased by 15.19% to $104.4 million in 2025, then dropped by 16.15% to $87.5 million in 2026.
- Per Business Quant, the three latest EXEL Accumulated Expenses figures stand at $87.5 million (Q2 2026), $102.2 million (Q1 2026), and $104.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 87.51 Mn |
| Jan 2, 2026 | 102.22 Mn |
| Oct 3, 2025 | 104.36 Mn |
| Jul 4, 2025 | 72.25 Mn |
| Apr 4, 2025 | 89.75 Mn |
| Jan 3, 2025 | 109.83 Mn |
| Sep 27, 2024 | 90.61 Mn |
| Jun 28, 2024 | 71.81 Mn |
| Mar 29, 2024 | 72.96 Mn |
| Dec 29, 2023 | 93.33 Mn |
| Sep 29, 2023 | 81.40 Mn |
| Jun 30, 2023 | 68.21 Mn |
| Mar 31, 2023 | 56.55 Mn |
| Dec 30, 2022 | 77.16 Mn |
| Sep 30, 2022 | 66.93 Mn |
| Jul 1, 2022 | 61.45 Mn |
| Apr 1, 2022 | 42.77 Mn |
| Dec 31, 2021 | 61.97 Mn |
| Oct 1, 2021 | 53.31 Mn |
| Jul 2, 2021 | 48.32 Mn |